Alignment Healthcare, Inc. (NASDAQ: ALHC) is a Healthcare company (Medical - Healthcare Plans) with a market capitalization of $1.6B. The Maz Rating grades it against the other companies in its sector.
Alignment Healthcare, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $7.62, Alignment Healthcare, Inc. trades at 53.4x trailing earnings, 0.3x sales and 5.7x book value, with an EV/EBITDA of 15.7. Over the last twelve months it generated about $5.0B of revenue and $30M of net income. It runs a gross margin of 11.9%, an operating margin of 0.9% and a net margin of 0.6%. It shows return on equity of 12.5%, return on invested capital of 7.2% and a free cash flow yield of 4.2%. On the balance sheet: a debt-to-equity ratio of 1.19 and a current ratio of 1.71. Over the past 52 weeks the share price ranged from $6.01 to $25.12, with a beta of 1.04.
Alignment Healthcare, Inc. does not currently pay a dividend.
16 Wall Street analyst ratings cover the stock: 12 Buy and 4 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.